These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12090973)

  • 1. Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
    Ravdin P
    Lancet; 2002 Jun; 359(9324):2126-7. PubMed ID: 12090973
    [No Abstract]   [Full Text] [Related]  

  • 2. New options in the prevention and treatment of breast carcinoma.
    Galleshaw J
    J Med Assoc Ga; 2003; 92(1):19-22. PubMed ID: 12743901
    [No Abstract]   [Full Text] [Related]  

  • 3. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.
    Baum M; Budzar AU; Cuzick J; Forbes J; Houghton JH; Klijn JG; Sahmoud T;
    Lancet; 2002 Jun; 359(9324):2131-9. PubMed ID: 12090977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
    Wu K; Brown P
    J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
    [No Abstract]   [Full Text] [Related]  

  • 5. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
    Gamucci T
    Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
    [No Abstract]   [Full Text] [Related]  

  • 6. Letrozole in breast cancer.
    Shahab N
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
    [No Abstract]   [Full Text] [Related]  

  • 7. [The ATAC study on adjuvants in breast cancer].
    Bravi S
    Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].
    Eiermann W
    MMW Fortschr Med; 2003 Dec; 145(50):8. PubMed ID: 14963963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
    Bergmann L
    Strahlenther Onkol; 2001 May; 177(5):273-4. PubMed ID: 11398617
    [No Abstract]   [Full Text] [Related]  

  • 10. Letrozole in breast cancer.
    Harris SR
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971059
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].
    Forciniti S
    Suppl Tumori; 2004; 3(4):S25-6. PubMed ID: 15206205
    [No Abstract]   [Full Text] [Related]  

  • 12. Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.
    Burstein HJ; Griggs JJ
    J Clin Oncol; 2012 Mar; 30(7):684-6. PubMed ID: 22271478
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.
    Burstein HJ
    N Engl J Med; 2003 Nov; 349(19):1857-9. PubMed ID: 14551340
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine treatment for ductal carcinoma in situ: balancing risks and benefits.
    Johnston SR
    Lancet; 2016 Feb; 387(10021):819-21. PubMed ID: 26686312
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of adjuvant trials of aromatase inhibitors in early breast cancer.
    Ingle JN
    Steroids; 2011 Jul; 76(8):765-7. PubMed ID: 21382394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
    DeGrendele H
    Clin Breast Cancer; 2003 Dec; 4(5):311-2. PubMed ID: 14715105
    [No Abstract]   [Full Text] [Related]  

  • 17. Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.
    Buzdar AU; Cuzick J
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1037s-1048s. PubMed ID: 16467122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anastrozole.
    Cuzick J
    Drugs Today (Barc); 2005 Apr; 41(4):227-39. PubMed ID: 16034487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
    Howell A; Cuzick J; Baum M; Buzdar A; Dowsett M; Forbes JF; Hoctin-Boes G; Houghton J; Locker GY; Tobias JS;
    Lancet; 2005 Jan 1-7; 365(9453):60-2. PubMed ID: 15639680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
    Nabholtz JM
    Am J Hosp Palliat Care; 2004; 21(6):457-65. PubMed ID: 15612238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.